Uncommon electrocardiographic presentation of an isolated right ventricular myocardial infarction.

Isolated right ventricular myocardial infarction is an extremely rare condition, and its diagnosis may be challenging. We present the case of a 63-year-old man who arrived at the emergency department with chest pain; electrocardiogram showed ST-segment elevation in precordial leads, for which, the diagnosis of anterior ST-elevation myocardial infarction was initially made. Coronary angiography showed diffuse coronary artery ectasia and total thrombotic occlusion of the right coronary artery that was treated by angioplasty and stenting, resulting in resolution of the chest pain and ST-segment elevation.

[Gender differences in mortality in patients with ST-segment elevation myocardial infarction].

Objective:: Women with ST-segment elevation myocardial infarction (STEMI) have worst outcomes than men. The objective of the study was to determine gender differences in mortality in patients with STEMI.

Methods:: Cohort study including patients with STEMI.

Evaluation of pharmacoinvasive strategy versus percutaneous coronary intervention in patients with acute myocardial infarction with ST-segment elevation at the National Institute of Cardiology (PHASE-MX).

Objective: The objective of PHASE-MX registry is to validate the efficacy and safety of the pharmacoinvasive strategy in comparison with percutaneous coronary intervention (PCI) in patients with acute myocardial infarction with ST segment elevation (STEMI) in a metropolitan region of Mexico. The primary outcome will consist of the composite of cardiovascular death, re-infarction, stroke and cardiogenic shock.

Methods: The PHASE-MX registry will include a prospective cohort of patients with STEMI who received reperfusion treatment (mechanical of pharmacological) in the first 12 h after the onset of symptoms.

Evaluation of pharmacoinvasive strategy versus percutaneous coronary intervention in patients with acute myocardial infarction with ST segment elevation at the National Institute of Cardiology (PHASE-MX).

Objective: The objective of PHASE-MX registry is to validate the efficacy and safety of the pharmacoinvasive strategy in comparison with percutaneous coronary intervention (PCI) in patients with acute myocardial infarction with ST segment elevation (STEMI) in a metropolitan region of Mexico. The primary outcome will consist of the composite of cardiovascular death, re-infarction, stroke and cardiogenic shock.

Methods: The PHASE-MX registry will include a prospective cohort of patients with STEMI who received reperfusion treatment (mechanical of pharmacological) in the first 12 h after the onset of symptoms.